» Articles » PMID: 24558429

Mir-184 Post-transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma

Overview
Journal PLoS One
Date 2014 Feb 22
PMID 24558429
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is one of the most common human malignancies and the third leading cause of cancer mortality worldwide. The development and progression of HCC is a complicated process, involving the deregulation of multiple genes that are essential to cell biological processes. Recently, microRNAs (miRNAs) have been suggested to be closely associated with tumorigenesis. Our study showed that miR-184 is upregulated in HCC cell lines and tissues. Overexpression of miR-184 in HCC cells increased cell proliferation, tumorigenicity, and cell cycle progression, whereas inhibition of miR-184 reduced cell proliferation, tumorigenicity, and cell cycle progression. Additionally, we identified SOX7 as a direct target of miR-184. Ectopic expression of miR-184 led to downregulation of the SOX7 protein, resulting in upregulation of c-Myc, Cyclin D1, and phosphorylation of Rb. Our findings suggested that miR-184 represents a potential onco-miR and plays an important role in HCC progression by suppressing SOX7 expression.

Citing Articles

Effects of light exposure during IVF: transcriptomic analysis of murine embryos and embryo-derived EVs.

Nagy B, Bognar Z, Csabai T, Fekete N, Buzas E, Kovacs A Front Immunol. 2025; 16:1429252.

PMID: 40051636 PMC: 11882875. DOI: 10.3389/fimmu.2025.1429252.


microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.

Fattahi M, Rezaee D, Fakhari F, Najafi S, Aghaei-Zarch S, Beyranvand P Cell Death Discov. 2023; 9(1):423.

PMID: 38001121 PMC: 10673883. DOI: 10.1038/s41420-023-01718-1.


The influence of adjunctive traditional Chinese medicine therapy on survival in primary liver cancer: a real-world study based on electronic medical records.

Zhao R, Wang L, Liu Y, Shao M, Yang W, Fu Y Front Pharmacol. 2023; 14:1231933.

PMID: 37790813 PMC: 10544965. DOI: 10.3389/fphar.2023.1231933.


MicroRNA and liver cancer.

Onishi M, Ochiya T, Tanaka Y Cancer Drug Resist. 2022; 3(3):385-400.

PMID: 35582451 PMC: 8992476. DOI: 10.20517/cdr.2019.110.


miR-184-5p inhibits cell proliferation, invasion and predicts prognosis of clear cell renal cell carcinoma by targeting NUS1 dehydrodolichyl diphosphate synthase subunit: Results from large-scale comprehensive identification and validation.

Liu W, Ma C, Xu H, Wang L, Xu W, Zhang H J Cancer. 2022; 13(5):1398-1409.

PMID: 35371326 PMC: 8965129. DOI: 10.7150/jca.58053.


References
1.
Gandillet A, Serrano A, Pearson S, Lie-A-Ling M, Lacaud G, Kouskoff V . Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood. 2009; 114(23):4813-22. DOI: 10.1182/blood-2009-06-226290. View

2.
Guo L, Zhong D, Lau S, Liu X, Dong X, Sun X . Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res. 2008; 6(9):1421-30. PMC: 2652859. DOI: 10.1158/1541-7786.MCR-07-2175. View

3.
Hagan J, Croce C . MicroRNAs in carcinogenesis. Cytogenet Genome Res. 2007; 118(2-4):252-9. DOI: 10.1159/000108308. View

4.
Seguin C, Draper J, Nagy A, Rossant J . Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell. 2008; 3(2):182-95. DOI: 10.1016/j.stem.2008.06.018. View

5.
Cho W . OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007; 6:60. PMC: 2098778. DOI: 10.1186/1476-4598-6-60. View